Ambroxol is indicated for:
Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Ambroxol is indicated for mucolytic therapy of productive cough associated with acute or chronic bronchopulmonary diseases.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: both men and women, only children (1 year - 12 years old)
Ambroxol is indicated for mucolytic therapy of productive cough associated with acute or chronic bronchopulmonary diseases.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Ambroxol is contraindicated in the following cases: